Blood Cancer Clinical Trial

This video is an overview of a clinical trial studying a new treatment called nuvisertib (TP-3654) for patients with myelofibrosis, a rare type of blood cancer. The study is testing whether adding nuvisertib to standard treatments can help improve symptoms and slow disease progression by targeting a protein involved in myelofibrosis. Researchers hope this treatment may also help patients who have stopped responding to current medications.